Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others. As of 25 May 2026, Bal Pharma share price is ₹89.45. The stock opened at ₹82.25, compared to its previous close of ₹82.03. During today's trading session, Bal Pharma share price moved in the range of ₹82.10 to ₹89.45, with an average price of ₹85.78 for the day. Looking at its last 52-week, the stock has touched a low of ₹82.10 and a high of ₹89.45.
The market capitalization of Bal Pharma is ₹130 Crs, with a P/E ratio of 16.0 and a dividend yield of 1.46%.